ADALIMUMAB-AATY for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 80 adverse event reports in the FDA FAERS database where ADALIMUMAB-AATY was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-AATY
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Intentional dose omission | 338 | 20.1% | 7 | 112 |
| Drug ineffective | 151 | 9.0% | 1 | 16 |
| Intentional product use issue | 151 | 9.0% | 8 | 29 |
| Death | 132 | 7.9% | 131 | 10 |
| Arthralgia | 96 | 5.7% | 2 | 15 |
| Rheumatoid arthritis | 94 | 5.6% | 5 | 7 |
| Fatigue | 92 | 5.5% | 3 | 14 |
| Therapy interrupted | 88 | 5.2% | 0 | 19 |
| Crohn's disease | 87 | 5.2% | 3 | 20 |
| Headache | 86 | 5.1% | 3 | 13 |
| Accidental exposure to product | 85 | 5.1% | 2 | 3 |
| Exposure via skin contact | 85 | 5.1% | 3 | 3 |
| Condition aggravated | 81 | 4.8% | 6 | 24 |
| Device malfunction | 80 | 4.8% | 1 | 2 |
| Nausea | 76 | 4.5% | 0 | 11 |